© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Health and Biotech

Top Section/Ad
More articles/Ad

More articles/Ad

More articles

  • ABS
    Coronavirus fears loomed over an otherwise benign SFVegas conference this week, with concerns over a pandemic trickling particularly into the aircraft segment. Sources say tangible cracks are beginning to show, with one deal shelved and spreads widening dramatically in the last week.
  • SSA
    The worsening of the Covid-19 outbreak has battered equity prices and sent investors scurrying for the safety of core government bonds. Most primary markets are all but shuttered, and investors are praying for central banks to provide a glimmer of hope.
  • Market participants should be braced for political volatility as the world comes close to experiencing a pandemic.
  • SRI
    Investors looking at the World Bank’s pandemic bond are discounting the price in the expectation that its principal will be written down by the spread of the Covid-19 epidemic, writes Jasper Cox.
  • Concerns over the impact of the Covid-19 coronavirus outbreak on the balance sheets of some of the biggest companies in the world led to four straight days of zero supply in the US high grade bond market this week.
  • Corporate bond spreads swung wider again on Thursday, surprising some investors and bankers with the severity of the moves, after they thought investment grade credit had dodged some of the biggest hits when global securities started plunging at the start of the week.